Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Operating Leases (2019 - 2025)

InspireMD filings provide 7 years of Operating Leases readings, the most recent being $3.3 million for Q4 2025.

  • On a quarterly basis, Operating Leases rose 83.18% to $3.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.3 million, a 83.18% increase, with the full-year FY2025 number at $3.3 million, up 83.18% from a year prior.
  • Operating Leases hit $3.3 million in Q4 2025 for InspireMD, up from $2.4 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $3.3 million in Q4 2025 to a low of $678000.0 in Q1 2022.
  • Median Operating Leases over the past 5 years was $1.1 million (2022), compared with a mean of $1.4 million.
  • Biggest five-year swings in Operating Leases: skyrocketed 5122.22% in 2021 and later plummeted 56.25% in 2024.
  • InspireMD's Operating Leases stood at $781000.0 in 2021, then skyrocketed by 53.01% to $1.2 million in 2022, then soared by 95.65% to $2.3 million in 2023, then decreased by 23.18% to $1.8 million in 2024, then surged by 83.18% to $3.3 million in 2025.
  • The last three reported values for Operating Leases were $3.3 million (Q4 2025), $2.4 million (Q3 2025), and $2.5 million (Q2 2025) per Business Quant data.